Champions Oncology, Inc. (CSBR)
4.99
+0.02
(+0.40%)
USD |
NASDAQ |
Oct 06, 16:00
4.99
0.00 (0.00%)
After-Hours: 20:00
Champions Oncology EPS Diluted (Quarterly) : -0.0306 for July 31, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | -0.0306 |
| April 30, 2026 | -0.048 |
| January 31, 2026 | -0.0201 |
| October 31, 2025 | 0.0185 |
| July 31, 2025 | -0.0338 |
| April 30, 2025 | -0.1334 |
| January 31, 2025 | 0.3129 |
| October 31, 2024 | 0.0519 |
| July 31, 2024 | 0.0935 |
| April 30, 2024 | -0.008 |
| January 31, 2024 | -0.1861 |
| October 31, 2023 | -0.1534 |
| July 31, 2023 | -0.19 |
| April 30, 2023 | -0.1891 |
| January 31, 2023 | -0.1799 |
| October 31, 2022 | -0.0012 |
| July 31, 2022 | -0.0236 |
| April 30, 2022 | -0.0255 |
| January 31, 2022 | 0.0547 |
| October 31, 2021 | 0.019 |
| July 31, 2021 | -0.0128 |
| April 30, 2021 | -0.0359 |
| January 31, 2021 | 0.0661 |
| October 31, 2020 | 0.0001 |
| July 31, 2020 | 0.0053 |
| Date | Value |
|---|---|
| April 30, 2020 | -0.1708 |
| January 31, 2020 | 0.0298 |
| October 31, 2019 | 0.0237 |
| July 31, 2019 | -0.0552 |
| April 30, 2019 | -0.0217 |
| January 31, 2019 | -0.0321 |
| October 31, 2018 | 0.019 |
| July 31, 2018 | 0.04 |
| April 30, 2018 | -0.0602 |
| January 31, 2018 | -0.01 |
| October 31, 2017 | -0.01 |
| July 31, 2017 | -0.06 |
| April 30, 2017 | -0.2207 |
| January 31, 2017 | -0.13 |
| October 31, 2016 | -0.05 |
| July 31, 2016 | -0.26 |
| April 30, 2016 | -0.30 |
| January 31, 2016 | -0.28 |
| October 31, 2015 | -0.29 |
| July 31, 2015 | -0.33 |
| April 30, 2015 | -0.48 |
| January 31, 2015 | -0.60 |
| October 31, 2014 | -0.60 |
| July 31, 2014 | -0.60 |
| April 30, 2014 | -0.4076 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Medpace Holdings, Inc. | 4.250 |
| Avantor, Inc. | 0.0563 |
| Personalis, Inc. | -0.3005 |
| Adaptive Biotechnologies Corp. | -0.2489 |
| 10X Genomics, Inc. | -0.138 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.426M |
| Revenue (Quarterly) | 15.23M |
| Total Expenses (Quarterly) | 15.66M |
| Enterprise Value | 76.35M |
| Gross Profit Margin (Quarterly) | 48.48% |
| Profit Margin (Quarterly) | -2.80% |
| Earnings Yield | -1.61% |
| Normalized Earnings Yield | -1.607 |